Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
68,603,587
-
Share change
-
-3,264,396
-
Total reported value
-
$4,671,894,132
-
Put/Call ratio
-
58%
-
Price per share
-
$68.10
-
Number of holders
-
234
-
Value change
-
+$222,754,372
-
Number of buys
-
158
-
Number of sells
-
115
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q3 2022
As of 30 Sep 2022,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,603,587 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, Pentwater Capital Management LP, STATE STREET CORP, PERCEPTIVE ADVISORS LLC, JPMORGAN CHASE & CO, FIL Ltd, UBS OCONNOR LLC, and GOLDMAN SACHS GROUP INC.
This page lists
234
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.